Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
12 Nov 2014
Transparency notification of Vanguard Health Care Fund
Read More
7 Nov 2014
UCB to sell its U.S. specialty generics business Kremers Urban to Advent International and Avista Capital Partners for US$ 1,525 million
Read More
28 Oct 2014
UCB enhances epilepsy presence in Japan and China: positive Phase 3 study for VIMPAT®
Read More
24 Oct 2014
UCB Interim Report for the first nine months of 2014: UCB continues the growth path
Read More
23 Sep 2014
Acquisition of own shares
Read More
16 Sep 2014
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density
Read More
1 Sep 2014
New indication for VIMPAT® (lacosamide): UCB’s anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures
Read More
1 Aug 2014
Transparency and Sharing: UCB Expands Access to Clinical Study Data
Read More
30 Jul 2014
UCB Half Year Report 2014: UCB: solid performance and pipeline delivery
Read More
23 Jul 2014
Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
45
Page
46
Page
47
Page
48
Current page
49
Page
50
Page
51
Page
52
Page
53
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss